Waterloo Capital’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Buy
4,797
+427
+10% +$180K 0.13% 158
2026
Q1
$1.65M Buy
4,370
+941
+27% +$403K 0.12% 164
2025
Q4
$1.47M Sell
3,429
-553
-14% -$241K 0.11% 167
2025
Q3
$1.78M Buy
3,982
+289
+8% +$131K 0.13% 151
2025
Q2
$1.8M Buy
3,693
+417
+13% +$238K 0.15% 140
2025
Q1
$2.02M Buy
3,276
+500
+18% +$284K 0.19% 122
2024
Q4
$1.47M Buy
2,776
+261
+10% +$147K 0.16% 140
2024
Q3
$1.51M Buy
2,515
+151
+6% +$85.6K 0.17% 135
2024
Q2
$1.28M Buy
2,364
+64
+3% +$36.7K 0.15% 131
2024
Q1
$1.48M Buy
2,300
+48
+2% +$29.2K 0.19% 115
2023
Q4
$1.32M Buy
2,252
+25
+1% +$14K 0.21% 109
2023
Q3
$1.16M Buy
2,227
+341
+18% +$177K 0.34% 63
2023
Q2
$1.02M Sell
1,886
-1
-0.1% -$547 0.3% 57
2023
Q1
$1.01M Buy
+1,887
New +$962K 0.31% 57
2020
Q1
$268K Buy
+618
New +$276K 0.19% 115

Other funds holding CHE

Waterloo Capital's CHE Position: Q2 2026 in Review

Waterloo Capital increased its Chemed (CHE) stake by 9.8% in Q2 2026, buying an estimated $180K and bringing the position to 4,797 shares worth $2.23M. The position accounts for 0.13% of the portfolio, ranked #158.

Waterloo Capital first reported a position in CHE in Q1 2020 and has held it in 15 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Waterloo Capital held 4,797 shares of Chemed worth $2.23M as of Q2 2026.
  • Waterloo Capital bought 427 Chemed shares in Q2 2026, an estimated $180K.
  • Chemed made up 0.13% of Waterloo Capital's portfolio in Q2 2026, its #158 holding.
  • Waterloo Capital first reported a position in Chemed in Q1 2020 and has held it in 15 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.